Treatment of posttramaumatic stress disorders in patients in in-patient addiction rehabilitation with the EMDR-method - a randomized controlled trial

Phase 3

Recruiting

• Conditions: F43.1; Post-traumatic stress disorder

• Registration Number: DRKS00009007
• Lead Sponsor: Gesellschaft für Rehabilitationswissenschaften Nordrhein-Westfalen e.V. (GfR)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-06-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 158

Inclusion Criteria

Substance use disorder according to DSM5 (305.00, 303.90, 291.9); at least subsyndromal PTSD according to DSM5, 309.81 (criteria A and B and at least one more criterion of C to E), assessed with the Clinician Administered PTSD-Scale; patient provided informed consent

Exclusion Criteria

Severe dissociative symptomatology (Dissociative Experiences Scale > 40); acute suicidality; acute psychotic symptomatology; severe cognitive impairments

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PTBS-symptoms, measured by the Clinician Administered PTSD Scale at 6-month-follow-up<br>

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes 6 months after treatment:<br>PTBS-Symptoms (PTSD Checklist for DSM-5); Alcohol use (mean amount of alcohol per day, number of abstinent days in the last month; Timeline Follow Back); Alcohol /substance use (Alcohol Use Disorders Identification Test; Drug Use Disorders Identification Test); Addiction-related problems (Addiction Severity Index) <br>Depressive symptoms (Beck Depression Inventory II); Dissociative symptoms (Dissociative Experiences Scale); Emotion regulation (Difficulties in Emotion Regulation Scale); Health-related quality of life (Short-Form 12-Item Health Survey)